Document is current

Article History

Received: 20 December 2022

Accepted: 17 March 2023

First Online: 4 May 2023

Declarations

:

: Informed consent was obtained from all participants involved in the study. All methods were carried out in accordance with relevant guidelines and regulations. The selected experts were considered a non-vulnerable population in the study context and participation was not classified as of particular risk. According to the “Guideline of the Ethics Committee for the Application of §§ 1 and 3 of the Ethics Procedural Rules of the University of Bremen”, the Ethics Committee of the University of Bremen is responsible for research projects in which there is a risk of impairment of physical or psychological integrity or a violation of community goods. In addition, according to German law ethical approval is only necessary for studies of interventional nature regarding medicinal products (medicinal products act, AMG) or medical devices (medical devices act, MPG). As this study wasn’t of interventional nature and due to the short duration of the study, no additional ethics approval was obtained, as available hearing dates did not correspond with the timeframe of the study. After receiving written information on the study including statements on data protection and concordance with the European General Data Protection Regulation (GDPR), participants of the expert interviews, online workshop and online survey provided written informed consent to participation, to analysis of the data obtained and to publication of anonymized results. Phrasing and content used in the written information and informed consent statements had previously been used in multiple studies of the research group after prior receiving approval by ethics committees, including the ethics committee of the German Society for Nursing Science.

: Not applicable.

: The authors have no conflicts of interest to declare that are relevant to the content of this article.